K PharmaInc (TSE:4896) - Stock Price, News & Analysis

4896 Stock Overview

Engages in the research, development, manufacture, and sale of regenerative medicines and pharmaceutical products in Japan. More details

4896 fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Has not reported any financial data

Volatile share price over the past 3 months compared to the JP market

Does not have a meaningful market cap (¥8B)

K Pharma,Inc. Competitors

RaQualia Pharma

TSE:4579

JP¥10.0b

Tsubota Laboratory

TSE:4890

JP¥11.3b

SymBio Pharmaceuticals

TSE:4582

JP¥11.7b

Nippon Chemiphar

TSE:4539

JP¥5.5b

Price History & Performance

Summary of all time highs, changes and price drops for K PharmaInc
Historical stock prices
Current Share Price	JP¥730.00
52 Week High	JP¥1,016.00
52 Week Low	JP¥531.00
Beta	0
11 Month Change	-5.93%
3 Month Change	-6.77%
1 Year Change	6.41%
33 Year Change	n/a
5 Year Change	n/a
Change since IPO	-22.91%

Recent updates

Shareholder Returns

	4896	JP Pharmaceuticals	JP Market
7D	-1.7%	-5.6%	-0.5%
1Y	6.4%	6.4%	10.8%

Return vs Industry: 4896 matched the JP Pharmaceuticals industry which returned 6.4% over the past year.

Return vs Market: 4896 underperformed the JP Market which returned 10.8% over the past year.

Price Volatility

Is 4896's price volatile compared to industry and market?
4896 volatility
4896 Average Weekly Movement	5.4%
Pharmaceuticals Industry Average Movement	3.6%
Market Average Movement	3.8%
10% most volatile stocks in JP Market	7.6%
10% least volatile stocks in JP Market	2.1%

Stable Share Price: 4896's share price has been volatile over the past 3 months compared to the JP market.

Volatility Over Time: 4896's weekly volatility (5%) has been stable over the past year, but is still higher than 75% of JP stocks.

About the Company

Founded	Employees	CEO	Website
2016	n/a	Hiroaki Fukushima	www.kpharma.co.jp

K Pharma,Inc. engages in the research, development, manufacture, and sale of regenerative medicines and pharmaceutical products in Japan. It develops regenerative medicine products using disease-specific induced pluripotent stem (iPS) cell technology for spinal cord injuries and cerebral infarctions.

K Pharma,Inc. Fundamentals Summary

How do K PharmaInc's earnings and revenue compare to its market cap?
4896 fundamental statistics
Market cap	JP¥8.47b
Earnings (TTM)	JP¥0
Revenue (TTM)	n/a

n/a

P/E Ratio

n/a

P/S Ratio

Is 4896 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
4896 income statement (TTM)
Revenue	JP¥0
Cost of Revenue	JP¥0
Gross Profit	JP¥0
Other Expenses	JP¥0
Earnings	JP¥0

Last Reported Earnings

n/a

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did 4896 perform over the long term?

See historical performance and comparison

K PharmaInc TSE:4896 Stock Report